Last update:

Gastroenterology news

Digital decision support tool proven to reduce risks in bowel surgery

Recent research provides robust evidence for the use of a digital visualization and decision support tool in colorectal (bowel) surgery. This is the first time that a digital decision support tool has been conclusively proven ...

Promising active substance against hepatitis E identified

Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a specific drug against this virus. This could change with the identification of bemnifosbuvir as a compound ...

Gut microbiome thrives on fiber—tapeworms confirm it

Intestinal worms can help reduce inflammation in the human body—but only if they have enough dietary fiber. Without it, they switch into a hibernation-like state and their protective effect disappears. This is the finding ...

Student shines a light on rare colon cancer

Colon cancer is one of the most common cancers in the U.S., with more than 100,000 cases diagnosed each year. But some people develop a highly aggressive form of colon cancer that is extremely rare, making up 0.02% to 0.1% ...

'Junk DNA' may help defend against colorectal cancer

For decades, large portions of the human genome were labeled "junk DNA." New research from Western University and London Health Sciences Centre Research Institute (LHSCRI) suggests these overlooked sequences may help protect ...

Recommendations developed for faltering weight in children

In a clinical practice guideline issued by the American Academy of Pediatrics, in partnership with the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, recommendations are presented for the ...

Berberine as a natural Ozempic? An analysis of a popular myth

In recent years, berberine has increasingly appeared in the public sphere as a "natural way" to improve metabolism. In social media, it is sometimes compared to incretin drugs and even referred to as "plant-based Ozempic." ...